🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

104 notícias encontradas para "option"
Foto: Tara Winstead / Pexels
Are lung cancer tumors hijacking the nervous system?
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment opti
Interpreters do more than translate, and patient care suffers when systems ignore it
At its heart, health care is a conversation. A patient needs to explain what is wrong. They need to understand their options. They need to make decisions about their own care. Clinicians need clear information, too. They need to understand symptoms, explain risks, discuss treatme
PET scans reveal stage-linked tau signal in Huntington's disease brains
A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the stage of Huntington's disease. This discovery opens the doo
Heroin-assisted treatment improves patients' health along with their quality of life
At two clinics in Oslo and Bergen, a small group of patients have been given a new treatment option for opioid addiction. Twice daily, they receive pharmaceutical heroin as medication, administered under close supervision and monitoring by health personnel.
What death doulas can teach us about dying well without religion
What death doulas can teach us about dying well without religion
In most Western societies, death has always been the church's job. Nearly everyone wanted last rites, deathbed prayers and a faith leader at their bedside. But for a growing number of people, that template for dying is no longer the only option. The death doula, a different kind
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i
Novel technology could aid targeted lung cancer treatment
Scientists have developed a new method for accurately predicting gene changes that cause lung cancer, without the need for slower, more expensive lab techniques. The technology was able to identify specific genetic changes with high accuracy, offering a potentially faster, more e
A conscious choice: Local and spinal anesthesia emerge as safer alternatives in spine surg
General anesthesia, once the default choice in spine surgeries, is increasingly giving way to local and spinal anesthesia as the preferred option for eligible patients. Since 2024, surgeons at Singapore General Hospital (SGH) have successfully performed more than 200 spine surger
Foto: Markus Winkler / Pexels
A new option for long-term care costs
An estimated 70% of Americans will need long-term care at some point in their lives, but "they haven't planned for it or saved for it," said Cathleen MacCaul, advocacy director for AARP Washington State, which supported the legislation that created WA Cares.
KRAS-targeting drugs show promise for rare appendix cancer
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.
Immunotherapy shows long-term promise in aggressive lymphoma
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical trial evaluated lisocabtagene maraleucel (liso-cel),
Researchers uncover new therapeutic vulnerability in one of the most aggressive childhood
Researchers uncover new therapeutic vulnerability in one of the most aggressive childhood
An international team led by the Josep Carreras Leukaemia Research Institute (IJC) in Barcelona, the Centre for Genomics and Oncological Research (GENyO) and the University of Granada (UGR) has identified a new biological vulnerability in one of the most aggressive forms of child